Table of Content

1 Genetic Vaccine Market Overview
1.1 Product Overview and Scope of Genetic Vaccine
1.2 Genetic Vaccine Segment by Type
1.2.1 Global Genetic Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Genetic Vaccine Segment by Application
1.3.1 Genetic Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Human
1.3.3 Animal
1.4 Global Genetic Vaccine Market Size Estimates and Forecasts
1.4.1 Global Genetic Vaccine Revenue 2016-2027
1.4.2 Global Genetic Vaccine Sales 2016-2027
1.4.3 Genetic Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Genetic Vaccine Market Competition by Manufacturers
2.1 Global Genetic Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Genetic Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Genetic Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Genetic Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Genetic Vaccine Market Competitive Situation and Trends
2.5.1 Genetic Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Genetic Vaccine Players Market Share by Revenue
2.5.3 Global Genetic Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Genetic Vaccine Retrospective Market Scenario by Region
3.1 Global Genetic Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Genetic Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Genetic Vaccine Market Facts & Figures by Country
3.3.1 North America Genetic Vaccine Sales by Country
3.3.2 North America Genetic Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Genetic Vaccine Market Facts & Figures by Country
3.4.1 Europe Genetic Vaccine Sales by Country
3.4.2 Europe Genetic Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Genetic Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Genetic Vaccine Sales by Region
3.5.2 Asia Pacific Genetic Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Genetic Vaccine Market Facts & Figures by Country
3.6.1 Latin America Genetic Vaccine Sales by Country
3.6.2 Latin America Genetic Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Genetic Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Genetic Vaccine Sales by Country
3.7.2 Middle East and Africa Genetic Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Genetic Vaccine Historic Market Analysis by Type
4.1 Global Genetic Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Genetic Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Genetic Vaccine Price by Type (2016-2021)

5 Global Genetic Vaccine Historic Market Analysis by Application
5.1 Global Genetic Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Genetic Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Genetic Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Genetic Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Genetic Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Genetic Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Corporation Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties Genetic Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Zoties Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Genetic Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Elanco Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer-Ingelheim
6.6.1 Boehringer-Ingelheim Corporation Information
6.6.2 Boehringer-Ingelheim Description and Business Overview
6.6.3 Boehringer-Ingelheim Genetic Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Boehringer-Ingelheim Product Portfolio
6.6.5 Boehringer-Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.6.1 Indian Immunologicals Corporation Information
6.6.2 Indian Immunologicals Description and Business Overview
6.6.3 Indian Immunologicals Genetic Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Indian Immunologicals Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 Plumbline Life Sciences
6.8.1 Plumbline Life Sciences Corporation Information
6.8.2 Plumbline Life Sciences Description and Business Overview
6.8.3 Plumbline Life Sciences Genetic Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Plumbline Life Sciences Product Portfolio
6.8.5 Plumbline Life Sciences Recent Developments/Updates

7 Genetic Vaccine Manufacturing Cost Analysis
7.1 Genetic Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Genetic Vaccine
7.4 Genetic Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Genetic Vaccine Distributors List
8.3 Genetic Vaccine Customers

9 Genetic Vaccine Market Dynamics
9.1 Genetic Vaccine Industry Trends
9.2 Genetic Vaccine Growth Drivers
9.3 Genetic Vaccine Market Challenges
9.4 Genetic Vaccine Market Restraints

10 Global Market Forecast
10.1 Genetic Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Genetic Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Genetic Vaccine by Type (2022-2027)
10.2 Genetic Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Genetic Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Genetic Vaccine by Application (2022-2027)
10.3 Genetic Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Genetic Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Genetic Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Genetic Vaccine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Genetic Vaccine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Genetic Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Genetic Vaccine Covered in This Study
Table 5. Global Genetic Vaccine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Genetic Vaccine Sales Share by Manufacturers (2016-2021)
Table 7. Global Genetic Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Genetic Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Genetic Vaccine Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Genetic Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Genetic Vaccine Product Type
Table 12. Global Genetic Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Genetic Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Genetic Vaccine Sales by Region (2016-2021) & (K Units)
Table 16. Global Genetic Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Genetic Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Genetic Vaccine Sales by Country (2016-2021) & (K Units)
Table 19. North America Genetic Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Genetic Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Genetic Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Genetic Vaccine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Genetic Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Genetic Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Genetic Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Genetic Vaccine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Genetic Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Genetic Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Genetic Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Genetic Vaccine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Genetic Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Genetic Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Genetic Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Genetic Vaccine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Genetic Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Genetic Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Genetic Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Genetic Vaccine Sales (K Units) by Type (2016-2021)
Table 39. Global Genetic Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Genetic Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Genetic Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Genetic Vaccine Price (USD/Unit) by Type (2016-2021)
Table 43. Global Genetic Vaccine Sales (K Units) by Application (2016-2021)
Table 44. Global Genetic Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Genetic Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Genetic Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Genetic Vaccine Price (USD/Unit) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Merck Genetic Vaccine Product
Table 52. Merck Recent Developments/Updates
Table 53. GSK Corporation Information
Table 54. GSK Description and Business Overview
Table 55. GSK Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. GSK Genetic Vaccine Product
Table 57. GSK Recent Developments/Updates
Table 58. Sanofi Corporation Information
Table 59. Sanofi Description and Business Overview
Table 60. Sanofi Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Sanofi Genetic Vaccine Product
Table 62. Sanofi Recent Developments/Updates
Table 63. Zoties Corporation Information
Table 64. Zoties Description and Business Overview
Table 65. Zoties Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Zoties Genetic Vaccine Product
Table 67. Zoties Recent Developments/Updates
Table 68. Elanco Corporation Information
Table 69. Elanco Description and Business Overview
Table 70. Elanco Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Elanco Genetic Vaccine Product
Table 72. Elanco Recent Developments/Updates
Table 73. Boehringer-Ingelheim Corporation Information
Table 74. Boehringer-Ingelheim Description and Business Overview
Table 75. Boehringer-Ingelheim Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Boehringer-Ingelheim Genetic Vaccine Product
Table 77. Boehringer-Ingelheim Recent Developments/Updates
Table 78. Indian Immunologicals Corporation Information
Table 79. Indian Immunologicals Description and Business Overview
Table 80. Indian Immunologicals Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Indian Immunologicals Genetic Vaccine Product
Table 82. Indian Immunologicals Recent Developments/Updates
Table 83. Plumbline Life Sciences Corporation Information
Table 84. Plumbline Life Sciences Description and Business Overview
Table 85. Plumbline Life Sciences Genetic Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Plumbline Life Sciences Genetic Vaccine Product
Table 87. Plumbline Life Sciences Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Genetic Vaccine Distributors List
Table 91. Genetic Vaccine Customers List
Table 92. Genetic Vaccine Market Trends
Table 93. Genetic Vaccine Growth Drivers
Table 94. Genetic Vaccine Market Restraints
Table 95. Global Genetic Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Genetic Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Genetic Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Genetic Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Genetic Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Genetic Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Genetic Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Genetic Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Genetic Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Genetic Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Genetic Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Genetic Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Genetic Vaccine
Figure 2. Global Genetic Vaccine Market Share by Type in 2020 & 2027
Figure 3. Recombinant Protein Vaccine Product Picture
Figure 4. Gene-Based Vaccine Product Picture
Figure 5. Global Genetic Vaccine Market Share by Application in 2020 & 2027
Figure 6. Human
Figure 7. Animal
Figure 8. Global Genetic Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Genetic Vaccine Market Size 2016-2027 (US$ Million)
Figure 10. Global Genetic Vaccine Sales 2016-2027 (K Units)
Figure 11. Global Genetic Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Genetic Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Genetic Vaccine Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Genetic Vaccine Players: Market Share by Revenue in 2020
Figure 15. Genetic Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Genetic Vaccine Sales Market Share by Region (2016-2021)
Figure 17. Global Genetic Vaccine Sales Market Share by Region in 2020
Figure 18. Global Genetic Vaccine Revenue Market Share by Region (2016-2021)
Figure 19. Global Genetic Vaccine Revenue Market Share by Region in 2020
Figure 20. U.S. Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Genetic Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Genetic Vaccine by Type (2016-2021)
Figure 45. Sales Market Share of Genetic Vaccine by Application (2016-2021)
Figure 46. Sales Market Share of Genetic Vaccine by Application in 2020
Figure 47. Revenue Share of Genetic Vaccine by Application (2016-2021)
Figure 48. Revenue Share of Genetic Vaccine by Application in 2020
Figure 49. Manufacturing Cost Structure of Genetic Vaccine
Figure 50. Manufacturing Process Analysis of Genetic Vaccine
Figure 51. Genetic Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed